Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer

Medical Hypotheses

Volumn 73, Issue 6, 2009, Pages 1005-1007

  Kim, Kidong ^a   Kim, Min Jeong ^b   Chung, Hyun Hoon ^b   Choi, Seok Cheol ^a   Ryu, Sang Young ^a   Kim, Jae Weon ^b   Park, Noh Hyun ^b   Song, Yong Sang ^b   Kang, Soon Beom ^b  

^a Korea Cancer Center Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFECT; GYNECOLOGIC SURGERY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 70449721137     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.05.026     Document Type: Article

References (14)

1. Horn L.C., Fischer U., Raptis G., Bilek K., and Hentschel B. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 107 (2007) 310-315
2. Sevin B.U., Nadji M., Lampe B., et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 76 (1995) 1978-1986
3. Cai H.B., Chen H.Z., and Yin H.H. Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer. J Obstet Gynaecol Res 32 (2006) 315-323
4. Chen H., Liang C., Zhang L., Huang S., and Wu X. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study. Gynecol Oncol 110 (2008) 308-315
5. Eddy G.L., Bundy B.N., Creasman W.T., et al. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol 106 (2007) 362-369
6. Napolitano U., Imperato F., Mossa B., Framarino M.L., Marziani R., and Marzetti L. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial. Eur J Gynaecol Oncol 24 (2003) 51-59
7. Sardi J.E., Giaroli A., Sananes C., et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 67 (1997) 61-69
8. Sardi J.E., Sananes C.E., Giaroli A.A., et al. Neoadjuvant chemotherapy in cervical carcinoma stage 2B: a randomized controlled trial. Int J Gynecol Cancer 8 (1998) 441-450
9. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003; 39: 2470-2486.
10. Kinoshita T., Takasugi M., Iwamoto E., Akashi-Tanaka S., Fukutomi T., and Terui S. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg 191 (2006) 225-229
11. Baslaim M.M., Al Malik O.A., Al-Sobhi S.S., et al. Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy. Am J Surg 184 (2002) 299-301
12. Bader A.A., and Tamussino K.F. Sentinel nodes might not reflect nodal status after neoadjuvant chemotherapy. Am J Surg 194 (2007) 135-136
13. Bader A.A., Winter R., Moinfar F., et al. Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer?. Gynecol Oncol 103 (2006) 106-112
14. Taucher S., Steger G.G., Jakesz R., et al. The potential risk of neoadjuvant chemotherapy in breast cancer patients - results from a prospective randomized trial of the Austrian breast and colorectal cancer study group (ABCSG-07). Breast Cancer Res Treat 112 (2008) 309-316